<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050451</url>
  </required_header>
  <id_info>
    <org_study_id>VU-IRB-131560</org_study_id>
    <nct_id>NCT02050451</nct_id>
  </id_info>
  <brief_title>Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy</brief_title>
  <official_title>A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status, Post-operative Complications, Length of Stay and Readmission Rates in Patients Undergoing Radical Cystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to assess the impact of an enriched oral nutritional shake
      (Ensure Plus®) to improve the nutritional status and patient outcome after surgery to remove
      a cancerous bladder (radical cystectomy). Radical cystectomy with urinary diversion using a
      segment of intestine is the standard of care for invasive bladder cancer. This operation has
      a high complication rate and several studies have shown that this may be directly related to
      poor nutrition.

      The investigators believe that patients who consume an enriched nutritional shake before and
      after surgery will improve their nutrition status and experience fewer complications, shorter
      length of stay and less readmissions compared to those who do not.

      Patients who are scheduled to undergo elective radical cystectomy will be eligible for
      enrollment. Once enrolled, they will be randomly assigned to one of two groups. One group
      will be offered Ensure Plus® twice daily for 2 weeks before and 4 weeks after their surgery
      and the other will be offered a daily over-the-counter multivitamin for the same period of
      time. The investigators will follow both groups for up to 30 days after their surgery and
      compare clinical outcomes such as: complication rates, length of stay, readmission rates and
      mortality as well as measure serum markers of nutrition status and assess changes in body
      composition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2014</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital-free days (HFDs)</measure>
    <time_frame>30 days</time_frame>
    <description>The study is powered to detect a difference in the number of HFDs over a 30 day period between intervention and control groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum markers</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare serum levels of albumin, prealbumin, transferrin and retinol binding protein and C-reactive protein between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will measure difference in lean body mass and fat mass between intervention and controls using whole body dual energy X-ray absorptiometry (DEXA) scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability / compliance</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will assess the patients' ability to tolerate and comply with the nutrition intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare the difference in rate, type and severity of post-operative complications between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare the length of stay following surgery between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare the rate of readmissions over the 30 day postoperative period between intervention and control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare overall survival between groups over the 30 day postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calories</measure>
    <time_frame>30 days</time_frame>
    <description>The investigators will compare caloric and nutrient intake between groups using comprehensive dietary assessment tools</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Nutrition Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ensure Plus®, consumed orally twice daily for 2 weeks before and 4 weeks after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Over the counter daily multivitamin for 2 weeks before and 4 weeks after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ensure Plus®</intervention_name>
    <arm_group_label>Nutrition Intervention</arm_group_label>
    <other_name>Ensure®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamin</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients eligible for elective radical cystectomy for bladder cancer at the
             sponsoring institution

        Exclusion Criteria:

          -  inability to tolerate oral supplementation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chad R Ritch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urologic Surgery, Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael S Cookson, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Urology, University of Oklahoma Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heidi J Silver, PhD, RD</last_name>
    <role>Study Director</role>
    <affiliation>Vanderbilt Center for Human Nutrition</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter E Clark, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Urologic Surgery, Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sam S Chang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Urologic Surgery, Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mc.vanderbilt.edu/root/vumc.php?site=urologicsurgery</url>
    <description>Vanderbilt University Department of Urologic Surgery</description>
  </link>
  <link>
    <url>http://www.mc.vanderbilt.edu/root/vumc.php?site=vchn</url>
    <description>Vanderbilt University Center for Human Nutrition</description>
  </link>
  <reference>
    <citation>Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson CJ Jr, Aghazadeh M, Smith JA Jr, Barocas DA. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol. 2011 Jan;185(1):90-6. doi: 10.1016/j.juro.2010.09.021. Epub 2010 Nov 12.</citation>
    <PMID>21074802</PMID>
  </reference>
  <reference>
    <citation>Stimson CJ, Chang SS, Barocas DA, Humphrey JE, Patel SG, Clark PE, Smith JA Jr, Cookson MS. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010 Oct;184(4):1296-300. doi: 10.1016/j.juro.2010.06.007. Epub 2010 Aug 17.</citation>
    <PMID>20723939</PMID>
  </reference>
  <reference>
    <citation>Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA Jr, Cookson MS. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011 Sep;186(3):829-34. doi: 10.1016/j.juro.2011.04.089. Epub 2011 Jul 23.</citation>
    <PMID>21788035</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2014</study_first_submitted>
  <study_first_submitted_qc>January 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2014</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Chad Ritch</investigator_full_name>
    <investigator_title>Clinical Instructor</investigator_title>
  </responsible_party>
  <keyword>radical cystectomy</keyword>
  <keyword>urinary diversion</keyword>
  <keyword>nutrition</keyword>
  <keyword>oral supplementation</keyword>
  <keyword>enteral nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

